Skip to main content

and
  1. Article

    Open Access

    Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers

    To develop and validate a radiomics model for evaluating treatment response to immune-checkpoint inhibitor plus chemotherapy (ICI + CT) in patients with advanced esophageal squamous cell carcinoma (ESCC).

    Ying Zhu, Wang Yao, Bing-Chen Xu, Yi-Yan Lei, Qi-Kun Guo, Li-Zhi Liu in BMC Cancer (2021)